Infectious Disease Diagnostic Market: Current Analysis and Forecast (2021-2027)

Infectious Disease Diagnostic Market is expected to exceed the market valuation of more than US$ XX billion in 2027 and is expected to grow at a significant CAGR of XX% during the forecast period (2021-2027). Infectious diseases are a broad term. There are a variety of illnesses and a wide number of microorganisms that can cause infectious diseases. Organisms causing infectious diseases includes parasites, bacterium, virus, or fungus. Most of these organisms are not life-threatening, however they can cause an array of illnesses training from mild to life threatening. These organisms can be transmitted from person to person by animal bites, or consuming contaminated food or water. Anyone can be affected by infectious diseases; however Immunocompromised individuals are at a greater risk of acquiring the infection. Infectious diseases can be treated with antibiotics (especially bacterial). Other infections like viral infections can be treated with antiviral medications and fungal infections can be treated with antifungals. Over time however, microorganisms are becoming resistant to drugs, thus one should always consider a doctor for the best treatment option.
The prevalence of infectious diseases has increased over the years globally. According to the World Health Organization, more than 13 million people die from infectious diseases each year. In some developing countries it leads to 1 in 2 deaths. The most vulnerable are the children, women, poor and the elderly. Infectious diseases are one of the leading cause of deaths around the world. Factors for the high occurrence of infectious diseases includes environmental, behavioral, and socio-economic factors. Additionally, migration and travel are also increasing the spread of these diseases. Infectious diseases pose significant threats to human health and can threaten international health security. To prevent this, on time diagnosis of the disease is required. This is possible with the growth of infectious disease diagnostics market.
Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMérieux SA, Thermo Fisher Scientific Inc., Danaher Corporation, Quidel Corporation, Hologic, Inc., Siemens Healthineers AG, Becton, Dickinson and Company, and PerkinElmer Inc. are some of the prominent players operating in the Infectious Disease Diagnostic market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst Products & Services, Consumables segment holds the major share”
Based on product & services the infectious diseases diagnostics market is segmented into consumables, instruments, and software & services. The consumables segment is expected showed the highest revenue and is expected to grow with the highest CAGR in the coming years. One can easily get a self-testing kit for various infectious diseases and these kits are recently gaining popularity. For example, during the coronavirus, Mylab Discovery Solutions released their self-use kits for covid virus testing which could show results in 15 minutes and costed around Rs. 250. They expect to sell 50-60 million kits a month.
“Amongst Disease Type, Tuberculosis segment holds the major share”
Based on disease type, the infectious disease diagnosis market is segmented into hepatitis, human immunodeficiency virus (HIV), hospital-acquired infections (HAIS), human papillomavirus (HPV), tuberculosis (TB), influenza, and other diseases. Tuberculosis had the highest revenue among all the disease types in this segment. Tuberculosis (TB) is caused by the bacteria Mycobacterium tuberculosis which effects the lungs. In 2019, a total of 1.4 million individuals died from tuberculosis worldwide. After tuberculosis, the major infectious disease type is HIV/AIDS. As of November 2020, HIV/AIDS has claimed a total of 34.7 million lives.
“Amongst Technology, Immunodiagnostics segment holds the major share”
Based on technology, the infectious disease diagnostics market is segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing and next-generation sequencing (NGS), DNA microarray technology, and other technologies. Immunodiagnostics had the highest revenue and CAGR growth in the analyzed period. Immunodiagnostics is a discipline that uses antigen-antibody reactions to detect molecules. This process can detect even a small number of molecules. This method has gained popularity in being a simple, fast, and accurate method in diagnosing a disease. This method can be used in detecting infectious diseases, autoimmune diseases, cancer, environment, food safety etc.
“Amongst End-User, Hospital/Clinical Laboratories segment holds the major share”
Based on End-User, the infectious diseases market is segmented into hospital/clinical laboratories, reference laboratories, academics/research institutes, and other end users. Hospitals/clinical laboratories earned the highest revenue in the infectious disease diagnostics market during the forecasted period. There are numerous laboratories in clinics and hospitals which specialize in performing diagnostic tests like blood tests, urine tests, throat swabs, etc. As of 2021, there are 29,227 Diagnostics and Medical Laboratories in the United States which is a 2% increase since 2020.
“North America represents one of the largest markets of Infectious Disease Diagnostic market”
For a better understanding of the market dynamics of the Infectious Disease Diagnostic market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Italy, United Kingdom, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC) and Rest of the World. North America dominated the market and grabbed around XX% market share owing to growing cases of infectious diseases.
Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry
Customization Options:
Infectious Disease Diagnostic market can further be customized as per the requirement or any other market segment. Besides this, understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.